Novogen’s (KZIA) Buy Rating Reiterated at BTIG Research

BTIG Research reiterated their buy rating on shares of Novogen (NASDAQ:KZIA) in a research note released on Wednesday morning,Benzinga reports. BTIG Research currently has a $34.00 price objective on the stock.

KZIA has been the topic of a number of other research reports. Laidlaw initiated coverage on Novogen in a research report on Wednesday, April 15th. They issued a “buy” rating and a $25.00 target price on the stock. Lake Street Capital started coverage on Novogen in a research note on Thursday, June 11th. They issued a “buy” rating and a $32.00 price objective for the company. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Novogen in a report on Tuesday, April 21st. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $25.80.

Novogen Price Performance

Novogen stock opened at $13.34 on Wednesday. The company’s 50 day simple moving average is $13.17 and its 200-day simple moving average is $9.79. Novogen has a 1 year low of $4.86 and a 1 year high of $17.40.

Novogen Company Profile

Novogen (NASDAQ:KZIA) is a clinical-stage biotechnology company focused on the discovery and development of novel small-molecule therapeutics for the treatment of cancer. The company’s pipeline includes GDC-0084, a brain-penetrant phosphoinositide 3-kinase (PI3K) inhibitor in Phase II development for glioblastoma, as well as Cantrixil, an orally bioavailable small molecule designed to target treatment-resistant ovarian cancer stem cells. Novogen’s research efforts leverage structure-based drug design to optimize selectivity and pharmacokinetic profiles, seeking to address high-unmet medical needs in oncology.

Founded in Australia and now headquartered in New York City, Novogen maintains research facilities in Perth and collaborates with academic institutions and contract research organizations worldwide.